MMR vaccines have an “unconscionably high injury rate” Kennedy wrote on CHD’s website in 2019, citing gastrointestinal and respiratory complications from a mid-1970s study.

Yet for one specific class of medicine, vaccines, this discussion is deliberately being made impossible. When researchers report an apparent side effect or adverse outcome, they can be near ...

The Centers for Disease Control and Prevention is expected to hand over multiple sets of vaccine safety data to a discredited researcher with a history of spreading misinformation that vaccines ...

Researchers have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against ...

The shingles vaccine, typically administered to fend off a painful rash, might pack an unexpected benefit by delaying or even preventing dementia. Groundbreaking research from Stanford University ...

Unfortunately, the best compliance with vaccines seems to depend on proximity to the illness. During the polio epidemic in the 1950’s parents saw thousands of children hospitalized and crippled ...

The U.S. Centers for Disease Control and Prevention (CDC) reportedly has plans to perform a large study on a “possible connection” between vaccines and autism—a topic of interest to Robert F.

The difference might have been luck, or it might have something to do with the world’s first malaria vaccine. It has been available at Ms Otieno’s local clinic in Migori county, in south ...

U.S.A.I.D. Advertisement Supported by Global Health A 281-page spreadsheet obtained by The Times lists the Trump administration’s plans for thousands of foreign aid programs. By Stephanie Nolen ...

Officials recommend that children get their first dose of the measles-mumps-rubella (MMR) vaccine between 12 and 15 months of age. Two doses of the vaccine are 97% effective against the measles virus.

WASHINGTON/PARIS, March 26 (Reuters) - President Donald Trump's administration plans to end U.S. funding for Gavi, an organization that helps buy vaccines for children in poor countries ...

A senior GSK scientist, who formerly worked at rival Pfizer, had told GSK colleagues that Pfizer delayed announcing the success of its Covid vaccine in 2020 until after that year’s election.